Skip to main content

Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2022

Novosanis will be attending the Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2022 conference on March 1 & 2. The conference will focus on the development of liquid biopsies utilizing circulating cell-free DNA (cfDNA), circulating tumour cells (CTCs) and other biomarkers found in biofluids.

Visit our booth to learn more about our unique urine collection & stabilization device, Colli-Pee. We look forward to seeing you there!

https://selectbiosciences.com/conferences/index.aspx?conf=EXLBPEU2022

Disclaimer

Effective December 8th, 2024, DNA Genotek™ will be the Legal Manufacturer of the Colli-Pee™ product family.
This transfer of all Colli-Pee™ devices to DNA Genotek™ as the new Legal Manufacturer will have no impact to product performance or how you place orders for the product. Please note that this change will have no impact on the Colli-Pee™ device design or specifications and there is no change to Colli-Pee™ device fit, form or function.

The Legal Manufacturing change will only result in changes to Colli-Pee™ device labelling to list DNA Genotek™ as the Legal Manufacturer. For a limited period of time, you may receive product with labelling indicating either Novosanis™ or DNA Genotek™ as the Legal Manufacturer on the product label. Both Novosanis™ and DNA Genotek™ are subsidiaries of OraSure Technologies, Inc.